Pimecrolimus cream in the management of patients with atopic eczema | Zendy

Jonathan M. Spergel | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Pimecrolimus cream in the management of patients with atopic eczema

Author(s) -

Jonathan M. Spergel

Publication year - 2009

Publication title -

clinical cosmetic and investigational dermatology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.73

H-Index - 35

ISSN - 1178-7015

DOI - 10.2147/ccid.s3377

Subject(s) - pimecrolimus , medicine , dermatology , atopic dermatitis , tacrolimus , atopy , allergy , immunology , surgery , transplantation

Atopic eczema is a common pediatric skin disorder. This review examines the use of pimecrolimus cream in the treatment of acute and chronic stages of the disease. The standard therapy is the treatment of acute flares with topical medications including pimecrolimus. The use of pimecrolimus cream for the first sign and symptoms of atopic eczema reduces the occurrence of flares as defined by the need for topical corticosteroids. The side effects of pimecrolimus cream are mild without any increase of infections or systemic immune suppression.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research